Showing results (1811-1820 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|August 15, 2026
Epigenetic Priming with Azacitidine Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid MalignanciesMohammad Alhomoud, Franco Castillo Tokumori, Nora Chokr, et al.
Transplantation and Cellular Therapy|August 15, 2026
Timing of Allogeneic Hematopoietic Cell Transplantation After Inotuzumab Ozogamicin Influences Sinusoidal Obstruction Syndrome and Survival in Relapsed/Refractory B-ALLAitana Balaguer-Roselló, Elena Bechtold Javier, Nuria Martínez-Cibrian, et al.
Transplantation and Cellular Therapy|August 14, 2026
Early Mortality and Conditional Long-Term Survival After Adult Umbilical Cord Blood Transplantation: A 1-Year Landmark AnalysisAmir Reza Akbari, Matthew L Braun, Nelson J Chao, et al.
Transplantation and Cellular Therapy|September 12, 2026
Treatment of severe acute graft-versus-host disease refractory to multiple lines of therapy: Real-world data from 317 adults treated with the multiple-donor bone marrow-derived mesenchymal stromal cell preparation tomostrocelM Verbeek, H Bonig, F Ayuk, et al.
Transplantation and Cellular Therapy|September 19, 2026
Prognostic Associations of Molecular MRD and Genomic Features in ZNF384-Rearranged B-ALL Undergoing Allo-HSCTXue-Shuang Zhang, Yan-Li Zhao, Jian-Ping Zhang, et al.
Transplantation and Cellular Therapy|September 17, 2026
Impact of a pharmacist-driven survivorship clinic on adherence to screening and preventive care after allogeneic hematopoietic cell transplantKelsea Seago, Autumn Smith, Spencer K Yingling, et al.
Transplantation and Cellular Therapy|September 17, 2026
Differences in Hematopoietic Cell Transplantation Outcomes by HIV status, California, 1991-2016Kurt A David, Ann Brunson, Sara J Schonfeld, et al.
Transplantation and Cellular Therapy|October 3, 2026
CAR T‑Cell Therapy as a Bridging Strategy to Second Transplant in Relapsed B‑Cell ALLVaibhav Agrawal, Haoyue Shan, Monzr Al Malki, et al.
Transplantation and Cellular Therapy|October 6, 2026
Infused CD34+ cell dose predicts response to stem cell boost in children with poor graft function following allogeneic hematopoietic stem cell transplantation: a multicenter study from the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)María Isabel Benítez-Carabante, Marina Ortiz-Palacios, Juan Antonio Carbonell-Asins, et al.
Transplantation and Cellular Therapy|October 15, 2026
Comprehensive, simplified, and objective comorbidity assessment before allogeneic hematopoietic cell transplantation: a comparative cohort studyLorenzo Iovino, Ningxin Ma, Chris Davis, et al.
Pageof 183